Logo image of BLEE.PA

BLEECKER (BLEE.PA) Stock Fundamental Analysis

EPA:BLEE - Euronext Paris - Matif - FR0000062150 - Common Stock - Currency: EUR

115  0 (0%)

Fundamental Rating

2

BLEE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. BLEE may be in some trouble as it scores bad on both profitability and health. BLEE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BLEE had negative earnings in the past year.
BLEE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BLEE reported negative net income in multiple years.
BLEE had a positive operating cash flow in each of the past 5 years.
BLEE.PA Yearly Net Income VS EBIT VS OCF VS FCFBLEE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

BLEE has a Return On Assets of -6.98%. This is amonst the worse of the industry: BLEE underperforms 88.10% of its industry peers.
With a Return On Equity value of -15.94%, BLEE is not doing good in the industry: 88.10% of the companies in the same industry are doing better.
BLEE has a worse Return On Invested Capital (1.50%) than 83.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BLEE is below the industry average of 3.57%.
The last Return On Invested Capital (1.50%) for BLEE is above the 3 year average (0.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.98%
ROE -15.94%
ROIC 1.5%
ROA(3y)-3.74%
ROA(5y)0.76%
ROE(3y)-8.73%
ROE(5y)0.96%
ROIC(3y)0.99%
ROIC(5y)0.83%
BLEE.PA Yearly ROA, ROE, ROICBLEE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Operating Margin of BLEE (38.10%) is worse than 76.19% of its industry peers.
BLEE's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 46.11%, BLEE is doing worse than 76.19% of the companies in the same industry.
In the last couple of years the Gross Margin of BLEE has grown nicely.
Industry RankSector Rank
OM 38.1%
PM (TTM) N/A
GM 46.11%
OM growth 3Y30.72%
OM growth 5Y9.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.22%
GM growth 5Y5.35%
BLEE.PA Yearly Profit, Operating, Gross MarginsBLEE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLEE is destroying value.
Compared to 1 year ago, BLEE has about the same amount of shares outstanding.
BLEE has about the same amout of shares outstanding than it did 5 years ago.
BLEE has a better debt/assets ratio than last year.
BLEE.PA Yearly Shares OutstandingBLEE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
BLEE.PA Yearly Total Debt VS Total AssetsBLEE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

BLEE has an Altman-Z score of 0.90. This is a bad value and indicates that BLEE is not financially healthy and even has some risk of bankruptcy.
BLEE has a Altman-Z score (0.90) which is comparable to the rest of the industry.
The Debt to FCF ratio of BLEE is 477.31, which is on the high side as it means it would take BLEE, 477.31 years of fcf income to pay off all of its debts.
BLEE has a Debt to FCF ratio of 477.31. This is amonst the worse of the industry: BLEE underperforms 80.95% of its industry peers.
A Debt/Equity ratio of 1.14 is on the high side and indicates that BLEE has dependencies on debt financing.
With a Debt to Equity ratio value of 1.14, BLEE is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 477.31
Altman-Z 0.9
ROIC/WACC0.35
WACC4.24%
BLEE.PA Yearly LT Debt VS Equity VS FCFBLEE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

BLEE has a Current Ratio of 0.87. This is a bad value and indicates that BLEE is not financially healthy enough and could expect problems in meeting its short term obligations.
BLEE has a Current ratio of 0.87. This is in the better half of the industry: BLEE outperforms 66.67% of its industry peers.
BLEE has a Quick Ratio of 0.87. This is a bad value and indicates that BLEE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.87, BLEE is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
BLEE.PA Yearly Current Assets VS Current LiabilitesBLEE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1

3. Growth

3.1 Past

BLEE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.73%.
The Revenue has been growing slightly by 2.86% in the past year.
The Revenue has been growing slightly by 7.33% on average over the past years.
EPS 1Y (TTM)-58.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.84%
Revenue 1Y (TTM)2.86%
Revenue growth 3Y11.64%
Revenue growth 5Y7.33%
Sales Q2Q%2.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLEE.PA Yearly Revenue VS EstimatesBLEE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

0

4. Valuation

4.1 Price/Earnings Ratio

BLEE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLEE.PA Price Earnings VS Forward Price EarningsBLEE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, BLEE is valued more expensive than 80.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 197.49
EV/EBITDA N/A
BLEE.PA Per share dataBLEE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BLEE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLEECKER

EPA:BLEE (7/15/2025, 7:00:00 PM)

115

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners71.74%
Ins Owner ChangeN/A
Market Cap129.95M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.34
P/FCF 197.49
P/OCF 16.11
P/B 0.5
P/tB 0.51
EV/EBITDA N/A
EPS(TTM)-36.76
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.58
FCFY0.51%
OCF(TTM)7.14
OCFY6.21%
SpS26.51
BVpS229.43
TBVpS226.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.98%
ROE -15.94%
ROCE 2.04%
ROIC 1.5%
ROICexc 1.51%
ROICexgc 1.52%
OM 38.1%
PM (TTM) N/A
GM 46.11%
FCFM 2.2%
ROA(3y)-3.74%
ROA(5y)0.76%
ROE(3y)-8.73%
ROE(5y)0.96%
ROIC(3y)0.99%
ROIC(5y)0.83%
ROICexc(3y)0.99%
ROICexc(5y)0.84%
ROICexgc(3y)1%
ROICexgc(5y)0.84%
ROCE(3y)1.34%
ROCE(5y)1.13%
ROICexcg growth 3Y47.05%
ROICexcg growth 5Y20.23%
ROICexc growth 3Y47.05%
ROICexc growth 5Y20.22%
OM growth 3Y30.72%
OM growth 5Y9.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.22%
GM growth 5Y5.35%
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 477.31
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 24.73%
Interest Coverage 0.79
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 0.9
F-Score5
WACC4.24%
ROIC/WACC0.35
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)23.61%
Cap/Sales(5y)36.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.86%
Revenue growth 3Y11.64%
Revenue growth 5Y7.33%
Sales Q2Q%2.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.04%
EBIT growth 3Y45.94%
EBIT growth 5Y17.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-85.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.4%
OCF growth 3Y120.64%
OCF growth 5Y3.91%